{"id":"https://openalex.org/W6993172367","doi":null,"title":"Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis: Results of the INJOURNEY trial","display_name":"Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis: Results of the INJOURNEY trial","alternate_titles":[],"publication_year":2018,"publication_date":"2018-02-01","ids":{"openalex":"https://openalex.org/W6993172367"},"language":"en","primary_location":{"id":"pmh:oai:dspace.library.uu.nl:1874/449038","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/449038","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"parent_works":[],"lineage":["https://openalex.org/W6993172367"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://dspace.library.uu.nl/handle/1874/449038","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"INJOURNEY Trial Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"INJOURNEY Trial Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Longziekten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Longziekten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Infection & Immunity","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Infection & Immunity","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":0.9079999923706055},{"id":"https://openalex.org/keywords/pirfenidone","display_name":"pirfenidone","score":1.0},{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.9570000171661377},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8610000014305115},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9020000100135803},{"id":"https://openalex.org/keywords/trough-concentration","display_name":"trough concentration","score":0.7760000228881836},{"id":"https://openalex.org/keywords/forced-vital-capacity","display_name":"forced vital capacity","score":0.9829999804496765},{"id":"https://openalex.org/keywords/antifibrotic-agents","display_name":"antifibrotic agents","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.9959999918937683},{"id":"https://openalex.org/C2779832356","wikidata":"https://www.wikidata.org/wiki/Q2060696","display_name":"Pirfenidone","level":4,"score":0.9266999959945679},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8601999878883362},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.767799973487854},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6798999905586243},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5961999893188477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5224000215530396},{"id":"https://openalex.org/C55520419","wikidata":"https://www.wikidata.org/wiki/Q660995","display_name":"Vital capacity","level":5,"score":0.39329999685287476},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3610000014305115},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.36039999127388},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3325999975204468},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3176000118255615},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2867000102996826},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.26499998569488525},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25060001015663147},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2500999867916107}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:dspace.library.uu.nl:1874/449038","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/449038","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:dspace.library.uu.nl:1874/449038","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/449038","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2810699055","https://openalex.org/W2555187162","https://openalex.org/W2146127863","https://openalex.org/W2768129576","https://openalex.org/W3094860528","https://openalex.org/W4200295215","https://openalex.org/W3163230142","https://openalex.org/W2418905634","https://openalex.org/W3047247202","https://openalex.org/W2788253332"],"abstract_inverted_index":{"Measurements":[0],"and":[1,22,63,78,94,126,149,156,164,166,175,185,269],"Main":[2],"Results:":[3],"On-treatment":[4],"gastrointestinal":[5,258],"adverse":[6,105,259],"events":[7,260],"were":[8,38,59,215,267],"reported":[9],"in":[10,54,67,97,101,119,170,241],"37":[11],"of":[12,24,36,108,122,131,151,254],"53":[13],"patients":[14,26,68,98,171,255],"(69.8%)":[15],"treated":[16,28,69,172],"with":[17,19,29,46,70,72,87,99,103,154,173,183,203,224,256],"nintedanib":[18,30,37,71,79,155,174,179,204,219,235],"add-on":[20,47,73,88,157,176,225],"pirfenidone":[21,74,89,127,177,226],"27":[23],"51":[25],"(52.9%)":[27],"alone.":[31,180],"Predose":[32],"plasma":[33],"trough":[34],"concentrations":[35],"similar":[39],"when":[40],"it":[41],"was":[42,251],"administered":[43],"alone":[44,80,240],"or":[45,189,212,234],"pirfenidone.":[48,158],"Mean":[49],"(SE)":[50],"changes":[51],"from":[52,261],"baseline":[53,262],"FVC":[55,186],"at":[56,194],"Week":[57,264],"12":[58,246],"213.3":[60],"(17.4)":[61],"ml":[62,66],"240.9":[64],"(31.4)":[65],"(n":[75,81],"=":[76,82],"48)":[77],"44),":[83],"respectively.":[84],"Conclusions:":[85],"Nintedanib":[86,125],"had":[90],"a":[91,198],"manageable":[92],"safety":[93,148],"tolerability":[95],"profile":[96],"IPF,":[100],"line":[102],"the":[104,120,129,137,147,252],"event":[106],"profiles":[107],"each":[109],"drug.":[110],"These":[111],"data":[112,143],"support":[113],"further":[114],"research":[115],"into":[116],"combination":[117,152],"regimens":[118],"treatment":[121,213],"IPF.":[123],"Rationale:":[124],"slow":[128],"progression":[130],"idiopathic":[132],"pulmonary":[133],"fibrosis":[134],"(IPF),":[135],"but":[136],"disease":[138],"continues":[139],"to":[140,191,200,217,228,263],"progress.":[141],"More":[142],"are":[144],"needed":[145],"on":[146],"efficacy":[150,168],"therapy":[153],"Objectives:":[159],"To":[160],"investigate":[161],"safety,":[162],"tolerability,":[163],"pharmacokinetic":[165],"exploratory":[167],"endpoints":[169],"versus":[178],"Methods:":[181],"Patients":[182],"IPF":[184],"greater":[187],"than":[188],"equal":[190],"50%":[192],"predicted":[193],"screening":[195],"who":[196],"completed":[197],"4-":[199],"5-week":[201],"run-in":[202],"150":[205,220,236],"mg":[206,221,230,237],"twice":[207,222,238],"daily":[208,223,239],"without":[209],"dose":[210],"reduction":[211],"interruption":[214],"randomized":[216],"receive":[218],"(titrated":[227],"801":[229],"three":[231],"times":[232],"daily)":[233],"an":[242],"open-label":[243],"manner":[244],"for":[245],"weeks.":[247],"The":[248],"primary":[249],"endpoint":[250],"percentage":[253],"on-treatment":[257],"12.":[265],"Analyses":[266],"descriptive":[268],"exploratory.":[270]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6993172367","counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}
